1. Home > Latest Topics >

Question 10: Safety profile of levofloxacin

20 June, 2018

Question 10
How does the safety profile of levofloxacin compare to -lactams and macrolides? 


LATEST TOPICS

Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024
Managing severe infections: Practical approaches for antibiotic use, including combination therapy
05 March, 2024
Updating Traditional Approaches: Expert Insights on Addressing Urinary Tract Infections
26 February, 2024
Antibiotic resistance may be driven by diverse factors, including extreme climatic events
14 February, 2024

RELATED ARTICLES

Community-acquired pneumonia: Insights into macrolide resistance and a review of levofloxacin use
05 July, 2021
Recent trends in the treatment of community-acquired pneumonia: A Japanese perspective
12 November, 2021
Klebsiella pneumoniae liver abscess: The impact of fluoroquinolones treatment on hospital length of stay
04 August, 2021
Community-acquired pneumonia: Updates in local treatment strategy and clinical experience with levofloxacin
07 October, 2021
Combination antibiotic therapy for penicillin non-susceptible Streptococcus pneumoniae
14 February, 2023